注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Scisparc Ltd(原名:Therapix Biosciences Ltd)是一家以色列製藥公司。該公司致力於建立和增強基於大麻素藥物的技術和資產。該公司正在進行基於大麻素(Dronabinol)再利用的藥物開發項目:THX-110用於治療抽動穢語綜合徵(TS)、阻塞性睡眠呼吸暫停(OSA)和疼痛;THX-130用於治療輕度認知障礙(MCI)和創傷性腦損傷(TBI);THX-150用於治療傳染病;以及THX-160用於治療疼痛。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Avi Weizman | - | 2016 | Member of Scientific Advisory Board |
Kirsten Müller-Vahl | - | 2016 | Member of Scientific Advisory Board |
Joseph Tam | - | - | Member of Scientific Advisory Board |
Daniele Piomelli | - | - | Member of Scientific Advisory Board |
Mellar P. Davis | - | - | Member of Scientific Advisory Board |
Michael H. Bloch | - | 2016 | Member of Scientific Advisory Board |
Alon Dayan | 46 | 2021 | Independent Director |
Amitai Weiss | 62 | 2020 | Chairman of the Board |
Moshe Revach | 47 | 2020 | Independent Director |
Itschak Shrem | 77 | 2020 | President & Director |
Michael Davidson | 74 | 2016 | Member of Scientific Advisory Board |
Elon Eisenberg | - | - | Member of Scientific Advisory Board |
Lior Vider | 48 | 2020 | Independent Director |
Liat Sidi | 49 | 2020 | Independent Director |
Saoirse O'Sullivan | - | - | Member of Scientific Advisory Board |
Amnon Ben Shay | 60 | 2021 | Independent Director |
Avi Schroeder | - | - | Member of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核